PerkinElmer spends $5.3B on its fourth acquisition this year

Life sciences giant PerkinElmer Inc. (NYSE: PKI) is making yet another acquisition, this time the biggest one in its history, buying San Diego, Calif.-based BioLegend for $5.25 billion in cash and stock. Goldman Sachs provided bridge financing for the deal. The transaction marks PerkinElmer's fourth such deal since the beginning of May. The Waltham company recently acquired SIRION Biotech GmbH, a German provider of viral vector-based technologies for use in cell and gene therapies, for an undisclosed…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news